| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.27 | 9e-10 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |